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Alopecia areata (AA) is an autoimmune disease of which the exact pathogenesis 
is poorly understood. There is conflicting evidence that psychosocial stress 
causes or exacerbates AA. A systematic literature search was undertaken 
focusing on studies describing the pathogenesis of AA and Hair cortisol 
concentration (HCC) as a biomarker of psychosocial stress. HCC is reported to 
be a reliable biological marker of stress. The estimated scalp hair growth rate of 
about one centimetre per month may be used to correlate cortisol levels with 
historic time-points depending on hair length. HCC may advance the debate on 




The primary objective was to determine whether stress acts as a trigger for (i.e. 
pre-dates) the onset of AA via objective measurement of HCC. 
                         
Two secondary objectives were identified: 
1. Using validated stress questionnaires to assess whether current stress 
correlates with HCC. 
2. To determine whether there is a difference in HCC of lesional versus peri-





A case control study was performed. Thirteen patients, fulfilling the inclusion 
criteria were recruited from the Groote Schuur Hopital (GSH) and Red Cross 
Hospital (RXH) outpatient departments. For each case consent was obtained, a 
data sheet was filled out, stress questionnaire(s) and two strands of hair, one 
lesional and one peri-lesional, were collected. Next, 13 healthy controls were 
recruited from whom a hair strand each was collected. 
On the hair samples, the position of onset of hair loss (OOHL) was determined by 
measuring one centimetre per month after OOHL, from the proximal (scalp near) 
end. Then three sections of three centimetres each were cut, two distally 
(representing the six-month period before OOHL) and one proximally (representing 
the three months post OOHL). In six of these cases a fourth or “current” section was 
obtained. This represented the section on the scalp and thus reflected current stress 
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by measuring the most recent HCC. Next, the HCC’s of these sections were 
measured using the Salivary ELISA Cortisol kit©. An additional 44 cases, not 
meeting the inclusion criteria, was recruited for acquisition of additional stress 




In all sections (except peri-lesional scalp), on average, the HCC’s of cases were 
higher than those of controls. Cases’ HHC’s were also more erratic as compared 
to the relative consistent values of the controls. In analysing the trends of the 
average HCC within samples over time, the distal sections proved to be the 
highest. This represents cortisol levels pre-OOHL. This is contrary to what is 
suggested by the washout effect (1) and could be expected from a spike triggering 
OOHL.  
 
When looking at the difference between the HCC of lesional versus peri-lesional 
sections, all lesional HCC readings were higher than that of the perilesional 
sections, except the mid-section. The trend of HCC over time with in a sample 
also seemed to differ. Lastly, the questionnaires showed the factors that 




The number of cases recruited was small and likely the reason for non-significant 
differences in all the above HCC comparisons. The extreme HCC values could 
have influenced average values, despite the methods that was followed to assure 





Higher and more erratic HCC’s of cases relative to controls could suggest that 
cortisol plays a role in AA. The higher HCC’s in distal sections (pre-OOHL) could 
reflect the true HCC pre-OOHL (at least in some cases). This is because the exact 
OOHL is difficult to determine and probably earlier. 
 
Higher HCC in lesional versus peri-lesional sections and also different trends 
within these samples suggests that local cortisol produced in the hair follicle could 
play a role in the presence or absence of disease in different areas of the scalp. 
Lastly, the results of the questionnaires could indicate that smoking is likely a 
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failed coping mechanism as a result of stress and older patients probably have 
more insight into the disease, better coping mechanisms and other, more 
significant, stressors. 
 
The data does suggest elevated HCC both pre OOHL and to a lesser extent 
versus normal scalp. This then lays the foundation for a larger study to 
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Alopecia areata (AA) is a form of lymphocyte mediated non-cicatritial alopecia. It 
is an autoimmune disease that targets the hair follicle where both genetic and 
environmental factors play a role in its susceptibility and severity. 
 
More than three quarters of patients affected with AA believe it is caused by stress 
(2). Quality of life is adversely influenced by the AA as well as the social aspect 
of the affected individual’s life (3). Although there are validated questionnaire 
based tools for the diagnosis of stress, their use in patients with alopecia is 
complicated by the fact that hair loss itself also causes significant anxiety and 
depression (4). Further, the assessment of past stress is subject to significant 
recall bias (5).  
 
Most questionnaires are only validated for stress experienced at present or the 
recent past (mostly within 6 months). It can therefore not measure stress for a 
specific time in the past. Thus, questionnaires are more useful for measuring 
current or ongoing stress and inevitably the results will include causes of current 
stress such as that caused by AA. So, the only useful questionnaire-based tool in 
retrospective assessment of stress would therefore be based on recalling 
verifiable stressful historic events occurring prior to the time frame of interest. 
This, however, does not allow for assessment of the resultant perceived stress 
on the individual. This makes the interpretation of results difficult - did the hair 
loss cause stress or was it the other way around (a chicken-and-egg situation).  
 
If a study had to be designed using only questionnaires, the only useful way would 
be to assess a population and prospectively look for disease. A more reliable 
measure of chronic stress is therefore needed in the form of objective biological 
marker(s) which would aid in evaluating the role of stress in the pathogenesis of 
disease. Recently, the validity of measuring cortisol in hair as a bio-marker of 
chronic stress has been documented (6-12). 
 




The first description of AA was by Celsus, Aulus (Aurelius) Cornelius, a Roman 
physician and medical writer (ca. 30 B.C.-45 A.D.). He described discrete and 
circular patches that progressed to complete hair loss. The first written use of the 
actual term, however, was by Sauvages in his “Nosologica Medica” in 1760.  The 
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word “alopecia” is derived originally from Greek alōpekia, literally ‘fox mange’ and 




Alopecia areata is the most prevalent autoimmune disorder with a lifetime 
incidence of approximately 2% worldwide (13) and represents 2-3% of skin 
disorders (14). It occurs in both men and women and in all age groups (15), but 
in occurs mostly in 30-59 year age group (16). Females are more commonly 
affected in a 2.3:1 ratio (17). Epidemiological data in Africa is not available, but it 
is commonly seen at our facility and in a study of 113 children with hair loss in 




Alopecia areata mostly manifests as round to oval alopecic patches on the scalp 
(hence the layman’s term “spot baldness”) with the affected skin otherwise 
clinically normal. It can, however, affect any hair bearing area on the body, the 
scalp being predominant in 90% of cases (19). When the whole scalp is involved, 
it is known as alopecia totalis, the whole body is involved, alopecia universalis 
and when the scalp margin is involved it is termed ophiasis. The natural history 
of this disorder is characterized by spontaneous remission, reoccurrence and 
exacerbation. Disease activity can be measured via the hair pull test (20) and the 
presence of regular round yellow dots on trichoscopy (dermoscopic imaging of 
the scalp and hair) can also indicate active disease (21). Clinical response can 
be measured via the severity of AA tool (22) (see figure 1). Cutaneous 
manifestations of AA other than the hair involvement include nail changes. The 
most common nail finding is fine pitting and other changes include ridging, nail 
plate thinning, twenty nail dystrophy, distal onycholysis, striate leukonychia and 
coarse pitting (23). However, nail changes are only seen in 10% of cases (21). 
 
2.4. Differential diagnoses 
 
In the case of the classic localised disease dermatoses mimicking AA may include 
resolving tinea capitis, trichotillomania, temporal triangular alopecia, traction 
alopecia, loose anagen syndrome, pressure-related alopecia, healed aplasia 
cutis and “burnt-out” cicatricial alopecia as well as systemic diseases like 




When dealing with the diffuse variant initial presentation may be misdiagnosed as 





In most instances, the history and clinical examination (with trichoscopy) is 
sufficient to confirm AA amongst these differentials. 
In less classic presentations, a scalp biopsy may prove useful. 
 
Trichoscopy  
The features of AA on trichoscopy include the presence of black dots, tapering 
hairs, broken hairs, yellow dots, and clustered short vellus hairs (24). 
 
Histology 
Pathological features in AA depend on the duration of the disease.In the early 
phase, the dermatopathologist will find a normal total number of hairs. The 
inflammatory component is that of a peribulbar mononuclear cell infiltrate often 
referred to as a “swarm of bees” (with occasional eosinophils). The inflammation 
predominantly is found affecting terminal anagen and catagen hair bulbs, but 
occasional exocytosis into bulbar epithelium is seen. Other findings include 
degenerative changes of hair matrix, more terminal catagen and telogen hairs as 
well as miniaturized hairs, trichomalacia and narrowing of hair shafts. 
 
In longstanding and stable disease, most hairs are found to be in catagen or 
telogen phases. Multiple miniaturized, “arrested”, rapidly cycling hairs are seen, 
known as nanogen hairs with mild peribulbar mononuclear cell infiltrate of 
anagen-like or catagen-like bulbs. 
 
Additional investigations may include special stains on histology and where 
indicated fungal cultures and serology for lupus erythematosus or syphilis. The 
increased association of autoimmune disease in patients with AA is not an 
indication for routine screening and should be indicated by clinical examination. 
Although one small case series found that iron deficiency is more common in 
females with AA (25), this was not confirmed in two subsequent studies (26, 27) 







2.6. Treatment and prognosis 
 
Because of the facts that AA runs an unpredictable course and can improve 
spontaneously, treatment guidelines have been formulated to facilitate treatment 
trials. The latest guidelines are from the  British Association of Dermatologists' of 
2012 (21). These state that AA does not pose any ill effects to general health and 
the level of aggression of treatment must be weighed up against the resultant 
psychological impact the disease has on the individual. 
 
For limited patchy hair loss, the current suggested treatment is super-potent 
topical steroids or intralesional corticosteroids (strength of recommendation C). 
For extensive patchy hair loss, alopecia totalis or universalis suggested treatment 
is contact immunotherapy (strength of recommendation C) and/or camouflage a 
wig or hairpiece (strength of recommendation D) (21). 
 
Continuous or pulsed systemic corticosteroids and PUVA currently are not 
recommended due to the potential for serious side-effects and inadequate 
evidence of efficacy. Dithranol (anthralin) and minoxidil lotion are safe, but there 
was previously little convincing evidence proving efficacy, however recently 
higher concentrations (0.5% versus 3%) of dithranol have been shown to be 
effective even in severe cases (28). 
 
The prognosis of AA is variable. Good prognosis is usually seen in cases of 
rapidly progressive AA regardless of the treatment as well as in those with 
persistent vellus hairs regardless of disease severity (29). Earlier onset and 
longer duration of disease were significantly associated with higher relapse and 




2.7.1. Autoimmunity and genetic predisposition 
 
Alopecia areata has been shown to be an autoimmune disorder (30). It is 
associated with various other autoimmune disorders including vitiligo, lupus 
erythematosus, psoriasis, atopic dermatitis, autoimmune thyroid diseases, and 
allergic rhinitis (31). The exact aetiology and pathogenesis of AA are currently 
unknown, but genetic (32) and environmental factors have been implicated (33, 
34). The hair follicle enjoys relative immune privilege via mechanisms including 
the down regulation of MHC classes I and II, less Langerhans cells and 
expression of immunosuppressive cytokines. In genetically predisposed 
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individuals, physical/emotional stress, infections, and hormones likely play a role 
in breakdown of this privilege (35-38). Vitamin D deficiency can aggravate AA 
severity (39, 40). Further, AA is characterized by a Th1-mediated immune 
response where CD8 cells infiltrate the follicle while CD4 cells are found in the 
perifollicular region (41-44). In a recent development a fully humanized animal 
model was achieved by transferring normal human NKG2D+ peripheral 
mononuclear cells onto human scalp transplanted onto severe-combined 
immunodeficient mice (30). The exact function of NKG2D+ peripheral 
mononuclear cells is an area earmarked for future research (34). 
 
2.7.2. Psychosocial stress 
 
The literature on the relationship between mental health and AA is contradictory 
ranging from studies finding that 93% of AA cases having a serious mental 
disorder (45) to studies reporting that psychological factors do not play any role 
in triggering AA (46). 
 
2.7.2.1 Subjective 
Environmental factors seem to play a role in triggering onset of AA and/or 
exacerbating the disorder. Cases have been found to have a higher number of 
stressful life events prior to onset of hair loss (47). Cases of stress-reactive AA 
have also been found to potentially suffer from depressive disorder (48). 
 
2.7.2.2 Objective 
Skin biopsies of alopetic skin shows increased staining for type 2 beta 
Corticotropin-releasing hormone (CRH) receptors around hair follicles which 
could have proinflammatory effects (49). In an experiment to prove that elevated 
Corticotropin-releasing factor (CRF) leads to cushing syndrome in mice, the CRF 
gene was expressed in transgenic mice showed bilateral symmetric hair loss (50). 
Similar models used by Wang also demonstrated diffuse hair loss and histology 
showed follicular atrophy and increased telogen hair (51). 
 
Plasma levels of Melanocyte-stimulating hormone (MSH) and cortisol were found 
not to be statistically different in AA cases as a potential measure of abnormal 
HPA functioning although there was a trend toward lower MSH and an increased 
cortisol (52). This once again is a short-lived value and does not necessarily 
correlate with past levels (i.e. preceding the onset of hair loss). 
 
 




Until recently, substrates for cortisol measurement have been serum, urine, and 
saliva. These only measure acute changes (past few hours to days) and thus do 
not reflect the stress response over prolonged time periods or a specific time 
period in the past. In addition, due to the diurnal variation in cortisol secretion 
samples either has to be collected at specific times of the day (saliva and serum), 
or require a laborious collection method (24 hour urine collection), making them 
unsuitable for population analysis (53). 
 
Apart from the ultradian and circadian rhythms that influence current cortisol 
levels it is also affected by nicotine (54), alcohol (55), food (56), exercise (57), 
injuries or hypoxemia (58) and acute psychosocial stress (59, 60). 
 
In the past few years, a new and uniquely different method to determine chronic 
cortisol exposure in man has been developed namely the measurement of cortisol 
in mammalian hair, with first evidence thereof in 2004 (61). Hair is a stable 
substrate that can be used to test for various exposures (drugs, toxins, nutrients, 
etc.) months-to-years before, depending on the length. The examination of 
cortisol in a specific hair segment is believed to provide a retrospective index of 
cumulative cortisol secretion over the time period during which the hair segment 
has grown (62). Recent studies have demonstrated that hair cortisol can reliably 
be measured. The validity of hair cortisol as a retrospective index of long-term 
cortisol secretion has now been supported by research using a range of different 
paradigms, both in animals (63, 64) as well as in human participants (7, 65-70). 
In addition, evidence has been reported confirming marker qualities of hair 
cortisol levels with regard to chronic stress and anxiety-related measures (6-12). 
Evidence for whether stressful life events raise cortisol levels have been 
conflicting (71, 72). 
 
The reference range for cortisol levels in hair of healthy non-obese individuals 
have been found to be 17.7-53.2 pg/mg of hair with a median of 46.1 pg/mg (65). 
 
Lipophilic compounds in the blood circulation (including cortisol), can primarily be 
incorporated into the hair following diffusion from capillaries supplying the hair 
into the growing hair follicle. When the hair then emerges from the scalp, the 
compound stays trapped within the inner hair shaft (73-75). Sebum and sweat 
secretions, together with external contamination post formation of the hair strand 




In the only meta-analysis up to date on hair cortisol concentrations, Stalder et al. 
showed a hair cortisol concentration (HCC) 21% higher in male versus female 
subjects. They also found HCC to increase with age and a decrease with time. 
When the proximal three centimetres section of hair was compared with the next 
three-centimetre section, a decrease of 29% was demonstrated. The deduction 
here was that different segments of hair in a particular case cannot serve as an 
internal control and that separate controls should be tested matching the same 
hair section of interest. Interestingly that although bordering on statistical 
significance neither hair washing frequency, hair treatments nor oral 
contraceptive use affected HCC’s and it is suggested that in most circumstances 
their influence is negligible. With regard to the physical laboratory testing enzyme-
linked immunosorbent assay (ELISA) protocols tested a higher HCC than liquid 
chromatography-based analyses. Inter-laboratory differences have been 
reported for various reasons, however good inter-laboratory correlations have 
been reported with the ELISA methods (1). 
 
With regards to sociodemographic variables and potential confounders, evidence 
is conflicting suggesting that neither age, gender, hair colour, hair products nor 
oral contraceptive significantly alter HCC. However, there is weak evidence that 
smoking may cause elevation in HCC and that HCC may decrease over time 
(washed out) (76) and with the dying or bleaching of hair (70). 
 
In recent study it has also been shown that elevated finger nail cortisol levels 
correlates with stressful events experienced (72) and so this could then prove to 
be another way to objectively measure past cumulative stress. 
 
4. Conclusions and research questions 
 
The exact pathogenesis of AA is poorly understood and multifactorial. There 
seems to be a strong belief and conflicting evidence that stress causes or 
exacerbates AA. Hair cortisol measurement has been proven to be a reliable 
biological marker for cumulative prior stress. This measurement has up to date 
not been performed in AA cases and may provide convincing evidence in the 
debate of stress and AA. 
 
Because hair on average grows one centimetre per month (77), it is possible to 
estimate based on hair-length how long ago specific cortisol levels were present, 




The primary aim of this project is therefore, to analyse the relationship between 
AA and stress (as measured HCCs); in cases versus controls and in cases pre-
dating onset of hair loss. 
Three secondary objectives were identified: 
• To determine whether there is a difference in HCC of lesional skin versus 
peri-lesional skin in cases.  
• To determine whether there is a correlation between disease activity (as 
determined by the hair pull test) and HCC. 
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Statements (70 words): 
 
 
• What is known about topic? 
The pathogenesis of alopcia areata is multifactorial and poorly understood. It is 
widely believed that stress is associated with onset of disease, but this remains 
to be proven. 
 
• What does this study add? 
Objective measurement of stress via hair cortisol concentration was assessed for 







The pathogenesis of alopecia areata (AA) is poorly understood and multifactorial. 
There seems to be a strong belief, but conflicting evidence that stress causes or 
exacerbates AA. Hair cortisol measurement has been proven to be a reliable 
biological marker for cumulative prior stress. This measurement has up to date 
not been used in AA cases and may provide convincing evidence in the debate 




The primary aim of this project was to determine whether stress triggers onset of 
hair loss (OOHL) in AA by analysing the relationship between hair cortisol 
concentrations (HCCs) pre-OOHL in cases vs controls. 
 
Three secondary objectives were identified: 
• To determine whether there is a difference in HCC of lesional skin versus 
peri-lesional skin in cases.  
• To determine whether there is a correlation between disease activity (as 
determined by the hair pull test) and HCC. 






A case control study was performed. Fourteen patients, fulfilling the inclusion 
criteria were recruited from the GSH and RXH outpatient departments. For each 
case consent was obtained, a data sheet was filled out, stress questionnaire(s) 
and two strands of hair, one lesional and one peri-lesional, were collected. Next, 
14 healthy controls were recruited from whom a hair strand each was collected. 
 
On the hair samples, the position of onset of hair loss (OOHL) was determined by 
measuring one centimetre per month after OOHL, from the proximal (scalp near) 
end. Then three sections of three centimetres each were cut, two distally 
(representing the six-month period before OOHL) and one proximally 
(representing the three months post OOHL). In six of these cases a fourth or 
“current” section was obtained. This represented the section on the scalp and 
thus reflected current stress by measuring the most recent HCC. Next, the HCC’s 
of these sections were measured using the Salivary ELISA Cortisol kit©. An 
additional 44 cases, not meeting the inclusion criteria, were recruited for 




HCC’s on average were higher in cases than in controls (before, during and after 
OOHL). The difference in HCC’s, however, was not statistically significant. There 
was no statistical difference between HCC’s in lesional and peri-lesional scalp 
samples. Distal section HCC’s were the highest. HCC’s correlated positively with 
disease activity, but was non-significant. There was no statistically significant 




Although the result was not statistically significant, likely due to small sample size, 
stress as measured by HCC may trigger OOHL in AA. HCC does not play a role 
in whether an area of the scalp is affected or not. Disease activity may be cause 






Alopecia areata (AA) is a form of lymphocyte mediated non-cicatritial alopecia. It 
is an autoimmune disease that targets the hair follicle where both genetic and 
environmental factors play a role in its susceptibility and severity. 
 
More than three quarters of patients affected with AA believe it is caused by stress 
(2). Although there are validated questionnaires for the diagnosis of stress, their 
use in AA is complicated by the fact that hair loss itself also causes significant 
anxiety and depression (4). Further, the assessment of past stress is subject to 
significant recall bias (5).  
 
Recently, the validity of measuring cortisol in hair as a bio-marker of chronic 
stress has been documented (6-8). The primary objective of this study was to 
determine whether stress pre-dates (i.e. can act as a trigger for) the onset of AA 
via objective measurement of hair cortisol concentrations (HCC’s).  
 
1.2 Materials and methods (or Patients and methods) 
 
1.2.1 Sample 
Approval for this case control study was obtained from the University of Cape 
Town Human Research Ethics Committee (HREC/REF 174/2015). Fourteen 
patients, fulfilling the inclusion criteria were recruited from the Groote Schuur and 
Red Cross Hospitals’ outpatient departments.  
 
Inclusion criteria: 
• Patient with AA on scalp. 
• OOHL within the past 12 months. 
• Remaining scalp hair at least three centimetres longer than the OOHL (one 
centimetre per month, reflecting three months after OOHL). 
 
Exclusion criteria: 
• On systemic steroid treatment. 
• Cushing’s syndrome/disease or clinically cushinoid. 
 
On each case, the following was obtained 
• Written consent 
• Data sheet 
• Stress questionnaires 
34 
 
‐ On cases, younger than 18; The Strengths and Difficulties 
questionnaire. 
‐ On cases, older than 18; the Kessler Psychological Distress Scale 
(K10) and the Self-Reporting Questionnaire 20-Item (SRQ-20) 
questionnaires. 
 
• Hair samples 
As can be seen in Figure 1, two strands of hair were shaven off the 
scalp. One at the periphery of the alopecia patch (“lesional”) and the 
other on the vertex in a clinically unaffected part of the scalp (“peri-
lesional”). Hair was pulled through a one-centimetre hole in a plastic 




Figure 1: Locations of hair sample collection 
 
An additional 44 cases, were recruited to obtain additional data from questionnaires. 
As can be seen in Figure 2, the final sample thus consisted of 14 cases HCC’s and 






Figure 2: Composition of sample 
 
Fourteen healthy controls were recruited from whom a hair sample each was 
collected from the vertex. They were controlled for age, gender and length of hair. 
 
On the hair samples, the position of onset of hair loss (OOHL) was determined by 
measuring one centimetre per month after OOHL, from the proximal (scalp near) 
end (figure 3). Then three sections of three centimetres each were cut, two distally 
(representing the six-month period before OOHL) and one proximally (representing 
the three months post OOHL). In six of these cases a fourth or “current” section was 














Figure 3: Cutting of hair samples into sections. 
 
The hair samples were rinsed in warm water (37°C for 15 seconds) to remove any 
water soluble and solid particles. Then, each sample was subjected to three, 
consecutive 3-minute wash cycles with isopropanol. The hair was put in tissue paper 
and allowed to dry overnight. The dried hair was pulverized using an Omni Bead 
Ruptor 24 (Omni International). For the cortisol extraction, approximately 20mg of 
hair was incubated in a glass tube with 1,5ml of methanol for 24 hours with shaking. 
The tubes were centrifuged 5minutes at 13000rpm and the cortisol extract collected 
and filtered through a 0.22um filter. 
 
1.2.2 Hair cortisol analysis 
 
The cortisol in the extracted samples was measured using the Salivary ELISA 
Cortisol kit© according to the manufacturer’s instructions with the reagents 
provided. The ELISA plates were read with a micro plate reader (Thermo Scientific 
Varioskan, USA) at 450 nm. A subset of the samples was validated using liquid 
chromatography mass spectrometry (LCMS). 
  
 
1.2.3 Data analysis  
 
The primary objective was to determine whether stress acts as a trigger for the 
onset of AA objectively via measurement of HCCs. In this regard, the difference 
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between lesional HCC’s of cases versus controls were assessed in all sections 
pre- and post OOHL. To allow for possible inaccurate dates of OOHL, the highest 
positive difference in HCC of the mid and distal segments for each case was also 
analysed to evaluate if statistical significant differences were possible. In this 
regard, to test for differences, the two-sample t-test was used. 
 
The first secondary objective was to determine whether there is a difference in 
HCC of lesional skin versus peri-lesional skin in cases. In this regard, once again, 
a two-sample t-test was employed.  
 
The second secondary objective was to determine the relationship between 
disease activity (as determined by the hair pull test) and lesional HCC. To assess 
this relationship, Point-biserial correlation analysis was employed. Since the hair 
pull test is measured by means of a dichotomous variable (1 = positive pull test, 
0 = negative pull test), and the HCC can be classified as ration data this method 
deemed appropriate. 
 
The third secondary objective was to determine the relationship between stress 
scores (as obtained through validated stress questionnaires) and lesional HCC’s 
(as determined by HCC in proximal sections). To assess this relationship, the 
Pearson correlation coefficient was employed. The Pearson correlation 
coefficient deemed appropriate given the nature of the underlying data (ratio 
data). Ratio data are numerical scales with order and exact differences between 
values. Ratio data also have an absolute zero. 
 
Three validated questionnaires were used for the third secondary objective: the 
K10, SRQ-20 and Strengths and Difficulties questionnaires. The K10 
questionnaire is used to measure psychological distress in adults. The numbers 
attached to the patients’ 10 responses are added up and the total score is the 
score on the Kessler Psychological Distress Scale (K10). K10 scores range from 
10 to 50. The SRQ-20 questionnaire was designed to screen or identify cases for 
psychiatric disturbance. Each of the 20 questions is scored 0 or 1. A score of 1 
indicates the symptom was present and 0 indicates the symptom was absent. The 
maximum score is therefore 20. The Strengths and Difficulties questionnaire 
(SDQ) is considered a valid, rapid measure for emotional and behavioural 
problems in children. The 25 items in the SDQ comprise of 5 scales of 5 items 
each. The total difficulties score is generated by summing scores from all the 









As can be seen in Table 1, a total of 58 cases were included in the study of which 
41 were female. 50 subjects were coloured, six black, one indian and one was 
white. The ages varied between four and 58 years old. The highest number of 
cases was in the third decade of life and the lowest the fourth and sixth, although 
the spread was relatively even with regards to the females. Males tended to be 
younger as were black patients. 
 




F M C B I W 
≤10 10 6 4 6 3 0 1 
11 - 20 11 6 5 10 1 0 0 
21 -30 13 8 5 12 1 0 0 
31 - 40 7 6 1 6 1 0 0 
41 - 50 10 9 1 9 0 1 0 
51 - 60 7 6 1 7 0 0 0 
Total 58 41 17 50 6 1 1 
 
With regards to HCC’s, samples on 14 cases with controls were obtained. As can 
be seen in Table 2, 7 (6) had lesional (peri-lesional) scalp samples, 13 (12) had 
lesional (peri-lesional) proximal samples, 12 (12) had lesional (peri-lesional) mid 
samples and 13 (10) had lesional (peri-lesional) distal samples available. On case 
9 only a proximal HCC’s could be obtained since the other samples were too small 
to obtain a reading. Case 13 did not have a peri-lesional sample and with case 
14 all the samples were too small to get a reading. Case 14 was omitted from any 
further HCC analysis. 
 
 




















1   1.52 - 1.74   1.46 1.64 - 1   5.69 5.30 3.34 
2 7.12 2.68 1.16 0.82 2.53 0.83 0.88 0.79 2 2.23 3.17 1.11 3.46 
3   2.38 5.96 4.62   11.42 24.2
9 
2.14 3   9.82 - 0.00 
4 110.7
8 
90.09 6.53 4.19 2.51 12.37 39.1
5 
3.26 4 2.20 1.43 1.35 2.30 
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5   8.15 21.1
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5   7.09 4.88 4.50 
6   6.65 4.00 2.10   3.93 1.06 - 6   3.45 1.54 3.32 








7   3.38 4.24 2.10 
8   1.77 1.05 0.68   13.68 3.03 1.94 8   3.86 - - 
9   0.37 <LO
Q 




9   1.52 1.91 0.68 






11 3.54 - - - 2.78 - - - 11 2.96 5.27 6.32 7.17 
12 2.75 2.50 3.10 2.28 3.83 3.05 3.14 1.83 12 4.27 6.07 6.49 3.30 
13 14.61 3.05 3.19 1.64 - - - - 13 1.89 0.87 0.75 1.07 








14. 2.75 1.89 3.49 4.38 
 
 
For the primary objective, to determine whether stress acts as a trigger for the 
onset of AA, the HCC’s of cases relative to that of controls were assessed. In 5 
instances (38.46%), the HCC of the cases were all higher than their matched 
controls and in 6 instances (46.15%) those of the controls were all higher. When 
combining the four sections (scalp, proximal, mid and distal), 19 (55.88%) of the 
case samples had higher HCC’s than the controls.  
 
As can be seen in Table 3, in all sections, on average, the HCC’s of cases were 
higher than those of controls. However, none of these differences were 
statistically significant. The highest difference was found to be scalp observation 
of cases vs controls followed by that of distal, proximal and mid sections.  
 
When specifically looking at the two sections corresponding to HCC prior to 
OOHL (mid and distal), the above non-significant finding holds true. In an attempt 
to accommodate the fact that OOHL is difficult to accurately determine and in 
some cases, may represent the mid- and in other the distal segments, we used 
the maximum positive difference in these two sections in all 13 cases. However, 
the deference was still not statistically significant. 
 
Table 3: Primary objective, two-sample t-test results 
 
  Lesional Case vs Control 
  Scalp Proximal Mid  Distal 
Greatest 
Difference 
(Mid and Distal) 
Average Difference 
(Case- Control) 19.22 6.86 3.27 19.16 22.66 
Std 18.13 7.59 4.07 21.82 66.72 
t-stat 1.06 0.90 0.80 0.88 1.07 




Average trends, as per figure 4, within lesional samples were also analysed. In 
cases, the highest HCC was the distal section, followed by the scalp, proximal 





Figure 4: Average HCC trend analysis by section in hair samples. 
 
For the first secondary objective, the difference between the HCC of lesional 
skin versus peri-lesional skin in cases was assessed. As can be seen in Table 4 
the average sections of lesional skin had higher HCC’s than their peri-lesional 
counterparts for all but the mid-section. The results of the two-sample t-tests 
were, however, non-significant for all the sections. 
 
Table 4: First secondary objective: two-sample t-test results 
 
  Scalp Proximal Mid Distal 
Average Difference  
(Lesional – Peri-Lesional) 22.46 5.99 -5.11 17.75 
STD 21.48 7.33 4.15 23.34 
t-stat 1.05 0.82 -1.23 0.76 
p-value 0.35 0.43 0.25 0.47 
 
For the second secondary objective, the relationship between disease activity 
(as determined by the hair pull test) and stress (as determined by HCC in proximal 















Eleven cases were available to perform this test. Ten had lesional proximal 
HCC’s, but for one case the scalp HCC was used. Six cases displayed a positive 
pull test and five did not. On average those cases with positive pull had higher 
HCC’s than those without. However, one of the positive pull HCC observations 
(case 4) seemed to be an extreme outlier in the dataset. 
 
Table 5 indicates the data and correlation between HCC and disease activity. The 
correlation coefficient was 0.35. However, this correlation coefficient was not 
statistically significant. 
 
Table 5: Relation of disease activity and HCC 
 
Case number Pull Test Lesional Proximal HCC 
2 Neg 2.68 
3 Neg 2.38 
10 Neg 5.03 
12 Neg 2.50 
13 Neg 3.05 
Average   3.13 
     
4 Pos 90.09 
5 Pos 8.15 
6 Pos 6.65 
7 Pos 15.72 
9 Pos 0.37 
11 Pos 3.54 
Average   20.76 
     








For the third secondary objective, the relationship between stress scores (as 
determined by validated stress questionnaires) and HCC’s (as determined by 




The scores obtained in the three validated stress questionnaires by the 58 cases 
surveyed can been observed in Table 6. 
Table 6: Questionnaire results 
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1 35 #N/A #N/A 
2 13 3 #N/A 
3 23 10 #N/A 
4 13 6 #N/A 
5 16 3 #N/A 
6 17 #N/A #N/A 
7 14 2 #N/A 
8 16 3 #N/A 
9 20 7 #N/A 
10 13 4 #N/A 
11 24 5 #N/A 
12 36 11 #N/A 
13 #N/A #N/A 13 






















15 20 5 #N/A 
16 21 8 #N/A 
17 23 #N/A #N/A 
18 14 0 #N/A 
19 15 #N/A #N/A 
20 32 11 #N/A 
21 13 3 #N/A 
22 23 6 #N/A 
23 23 9 #N/A 
24 17 3 #N/A 
25 17 #N/A #N/A 
26 13 3 #N/A 
27 40 11 #N/A 
28 14 4 #N/A 
29 37 16 #N/A 
30 42 11 #N/A 
31 12 4 #N/A 
32 30 13 #N/A 
33 30 11 #N/A 
34 28 10 #N/A 
35 16 3 #N/A 
36 15 5 #N/A 
37 25 6 #N/A 
38 #N/A 13 #N/A 
























The ranges of scores, interpretation and results with regards to the sample of 37 
cases who completed the K10 questionnaire can be seen in Table 7. 
 
Table 7: K10 interpretation 
 
Range Patient likely to # of participants % of participants 
< 20 be well 17 45.95% 
20 – 24 experience mild stress 8 21.62% 
25 -29 experience moderate stress 3 8.11% 
30 + experience severe stress 9 24.32% 
  37 100% 
 
Most cases fell in the category of being well and second most of the cases fell in 
the category of being severely stressed. On average, the K10 stress score was 
22.19 which falls in the category of experiencing mild stress. 
 
The ranges of scores, interpretation and results with relation to the sample of 34 




40 28 11 #N/A 
41 33 15 #N/A 
42 #N/A #N/A 2 
43 #N/A #N/A 6 
44 #N/A #N/A 8 
45 #N/A #N/A 15 
46 #N/A #N/A 9 
47 #N/A #N/A 10 
48 #N/A #N/A 24 
49 #N/A #N/A 4 
50 #N/A #N/A 21 
51 #N/A #N/A 13 
52 #N/A #N/A 14 
53 #N/A #N/A 21 
54 #N/A #N/A 10 
55 #N/A #N/A 18 
56 #N/A #N/A 25 
57 #N/A #N/A 14 
58 #N/A #N/A 28 
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Table 8: SRQ-20 interpretation 
 
Range Threshold # of participants % of participants 
< 8 below 20 58.82% 
8 + above 14 41.18% 
  34 100% 
 
Most cases fell below the threshold. The average SRQ-20 score was 6.97 which 
is slightly below the threshold. 
 
The ranges of scores, interpretation and results with regards to the sample of 19 
cases who completed the SDQ questionnaire can be seen in Table 9. 
 
Table 9: SDQ interpretation 
 
Range Interpretation # of participants % of participants 
0 - 16 Normal 13 68.42% 
17 - 19 Borderline 1 5.26% 
20 - 40 Abnormal 5 26.32% 
  19 100% 
 
Most cases fell in the category of being normal and second most of the cases fell 
in the category of being abnormal. On average, the SDQ score was 14.11 which 
falls in the normal category. 
 
As can be seen in Table 10, the relation between HCC and the K10 were negative, 
but non-significant. The correlation between the SRQ20 score and HCC indicated 
very close to no relation at all. 
 






















The demographics are skewed by the fact that significantly more women than 
men were included in the study when compared to the actual incidence. This can 
likely be ascribed to the fact that women tend to wear longer hairstyles which 
were searched out to fulfil the primary objective. Another factor could be that it is 
likely more of a cosmetic concern for women and thus they probably tended to 
seek out medical attention more aggressively and was probably also more willing 
to participate in the study in an attempt to remedy their situation. The aim of the 
study was not incidence, though. The high number of coloured cases included in 
the sample is due to the demographic of the drainage area. The higher number 
seen in their third decade of life is in keeping with international incidence. 
 
With regards to the primary objective the average HCC of the four sections of 
cases proved to be higher than those of controls, with no statistical difference. 
Together with the scalp section the highest difference was actually the distal 
section, corresponding to HCC pre OOHL. This could possibly signify stress 
triggering OOHL. The high difference in the scalp section could then reflect the 
resultant stress caused by the AA.  
 
Interestingly, though, in terms of trends within each hair sample, the average 
distal HCC’s were the highest of the four (figure 4). This could signify a HCC spike 
before OOHL, once again pointing to stress triggering OOHL. It has been shown 
in controls as well, however, to a much lesser degree. This is contrary to the 
decline that is found the more distal sections are from the scalp, the so called 
“wash-out effect” (75). Another interesting observation is that although neither the 
cases nor the control HCC’s over time differed significantly, one can appreciate 
the fluctuation in HCC’s of the cases versus the relative constant HCC’s of 
controls (figure 4). 
 
With regards to the first secondary objective, there was no difference shown 
between the HCC of lesional vs non-lesional sections, meaning that local cortisol 
is probably not the reason why in an individual with AA certain areas of the scalp 
are affected and others not. 
 
When looking at the correlation of disease activity and HCC’s under the second 
secondary objective, it proved to be positive as expected, but non-significant. 
This shows that stress could possibly trigger disease activity or active disease 
cause stress as measured. 
 
In the third secondary objective, the relation between HCC and validated 
questionnaires was negative. Although non-significant, this was unexpected and 
could be explained by an extreme outlier as well as the fact that there were few 




Due to the small sample size and the pilot nature of the study, statistical 





Although AA is commonly seen in our facility, the number of cases recruited is 
small. This is because OOHL tended to be more than 12 months prior in most 
instances at the time of first assessment. The likely explanation is the fact that 
this is a referral institution where the load is quite significant leading to a delay 
with initial contact with the division. Many potential candidates also had non-shed 
hair that was too short to obtain segments predating the OOHL. OOHL is also 
difficult to precisely determine. This is due to the fact that patients often don’t 
discover the problem themselves since unlike conditions like telogen effluvium 
the hair that is lost is often not so dramatic and the bald patch gets pointed out by 
someone else, i.e., their hairdresser. The condition is also asymptomatic. 
With regards to the HCC’s extreme values occurred which could have influenced 
average values, despite the methods that were followed to assure correct 
readings. 
 
1.6 Conclusion and recommendations 
 
The number of cases recruited was small and likely the reason for non-significant 
differences in all two-sample t-tests performed to do HCC comparisons. Stress 
could possibly trigger OOHL in AA as suggested by the following: 1) HCC’s of 
cases were higher than controls, 2) HCC pre-OOHL was the highest section in 
the hair samples of cases and 3) the difference between the HCCs of cases 
versus controls were also highest pre-OOHL (together with the scalp near section, 
possibly signifying the expected stress caused by AA).  Cases’ HHC’s were erratic 
as compared to the relative consistent values of the controls. This then lays the 
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